| Literature DB >> 23766790 |
Sushil K Maurya1, Mark Dow, Stuart Warriner, Adam Nelson.
Abstract
A range of metathesis substrates was assembled from triplets of unsaturated building blocks. The approach involved the iterative attachment of a propagating and a terminating building block to a fluorous-tagged initiating building block. Metathesis cascade chemistry was used to "reprogram" the molecular scaffolds. Remarkably, in one case, a cyclopropanation reaction competed with the expected metathesis cascade process. Finally, it was demonstrated that the metathesis products could be derivatised to yield the final products. At each stage, purification was facilitated by the presence of a fluorous-tagged protecting group.Entities:
Keywords: alkaloids; cyclopropanes; diversity-oriented synthesis; metathesis
Year: 2013 PMID: 23766790 PMCID: PMC3678641 DOI: 10.3762/bjoc.9.88
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.883
Scheme 1Illustrative examples of a synthetic approach to natural-product-like molecules with over eighty molecular scaffolds.
Scheme 2Overview of the proposed synthetic approach. FDIPES = diisopropyl(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)silyl; Ns = o-nitrophenylsulfonyl.
Figure 1Structures of building blocks used in this study. Panel A: fluorous-tagged initiating building blocks. Panel B: propagating building blocks. Panel C: terminating building blocks.
Scheme 3Synthesis of the initiating building blocks 6a and 6b. TBD = 1,5,7-triazabicyclo[4.4.0]dec-5-ene.
Scheme 4Synthesis of the initiating building block 7.
Attachment of propagating building blocks to the fluorous-tagged initiating building blocks.
| Building blocks | Attachment | Deacetylationa | Product |
| Methoda (mass recovery / %) | Mass recovery / % | ||
| A1 (70) {>98} | 92 (92) | ||
| A2 (97) {92} | 87 (93) | ||
| A3 (85) {>98} | 87 (98) | ||
| A3 (85) {76} | 85e (72) | ||
| A3 (92) {91} | 94f | ||
| A3 (74f) | 97 (98) | ||
| A3 (97) {91} | 80f | ||
aMethods: A1: Initiating building block (1.0 equiv), propagating building block (4.0 equiv), DEAD (4.0 equiv), PPh3 (4.0 equiv), CH2Cl2, 0 °C → rt then F–SPE; A2: Initiating building block (1.0 equiv), propagating building block (4.0 equiv), DEAD (2.0 equiv), PPh3 (2.0 equiv), CH2Cl2, 0 °C → rt then F–SPE; A3: Initiating building block (1.0 equiv), propagating building block (4.0 equiv), DEAD (2.0 equiv), PPh3 (2.0 equiv), THF, 0 °C → rt then F–SPE; Deacetylation: 0.025 M NH3 in MeOH. bDetermined by analysis of the 500 MHz 1H NMR spectrum. cThe building block had >98% ee. dThe building block had 68% ee. eIsolated as a ca. 75:25 mixture of diastereoisomers. fIsolated yield of purified product (see Supporting Information File 1).
Attachment of propagating building blocks to the fluorous-tagged initiating building blocks.
| Substrate | Terminating building block | Attachment | Product |
| Methoda (mass recovery / %) | |||
| A4 (89) {83} | |||
| A4 (89) {86} | |||
| A4 (76) {93}] | |||
| A4 (75) {97} | |||
| A5 (62c) | |||
| A5 (54c) | |||
| A5 (86c,e) | |||
| A5 (77c,e) | |||
| A6 (86c) | |||
| A6 (77c) | |||
| A6 (92c) | |||
| A6 (55c) | |||
| A6 (85c) | |||
aMethods: A4: Substrate (1.0 equiv), propagating building block (4.0 equiv), DEAD (2.0 equiv), PPh3 (2.0 equiv), CH2Cl2, 0 °C → rt then F-SPE; A5: Substrate (1.0 equiv), propagating building block (4.0 equiv), DEAD (4.0 equiv), PPh3 (4.0 equiv), THF, 0 °C → rt then F-SPE; A6: Substrate (1.0 equiv), propagating building block (4.0 equiv), DEAD (2.0 equiv), PPh3 (2.0 equiv), THF, 0 °C → rt then F-SPE. bDetermined by analysis of the 500 MHz 1H NMR spectrum. cIsolated yield of purified product. dThe starting material was a ca. 75:25 mixture of diastereoisomers. eIsolated as a ca. 75:25 mixture of diastereomers.
Application of cascade metathesis reactions in the synthesis of diverse scaffolds and subsequent desulfonylation.
| Substrate | Methoda (mol %; time) | Product | Yield / % |
| B1 (5 + 2.5; 3 d) then C1 | |||
| B1 (2 × 5; 4 d) then C1 then D | 43%b | ||
| B1 (5 + 5 + 2.5; 10 d) then C1 | 49%b (86%c) | ||
| B1 (4 × 5; 20 d) then C1 | 77 then 81 (93%c) | ||
| B1 (3 × 5; 14 d) then C1 | 63 then 85 ( | ||
| 29 then 94 ( | |||
| B1 (4 × 5; 20 d) then C2 | 8%b | ||
| B2 (5; 24 h) then C1 | 93 then 96 (87%c) | ||
| B2 (5; 24 h) then C2 | 93 then 80 (93%c) | ||
| B2 (3 × 5; 7 d) then C1 | 76 then 92 (92%c) | ||
| B2 (2 × 5; 3 d) then C2 | 54 then 77 (86%c) | ||
| B2 (5; 24 h) then C1 | 53 then 99 (98%c) | ||
aMethods: B1: Hoveyda–Grubbs second-generation catalyst, CH2Cl2, 50 °C then Et3N (86 equiv), P(CH2OH)3 (86 equiv) then silica; B2: Hoveyda–Grubbs second-generation catalyst, MTBE, 50 °C then Et3N (86 equiv), P(CH2OH)3 (86 equiv) then silica; C1: PhSH (1.2 equiv), K2CO3 (3.0 equiv), DMF; C2: PhSH (2.4 equiv), K2CO3 (6.0 equiv), DMF; E: aq HF, MeCN–CH2Cl2. bYield over more than one step. cPurity of the product determined by 500 MHz 1H NMR spectroscopy. dThe starting material was a ca. 75:25 mixture of diastereoisomers.
Scheme 5Fate of the metathesis reaction of the substrate 32.
Derivatisation and deprotection of final products.
| Substrate (puritya / %) | Productb | Methodc | Yield / % | |
| D | 51 | |||
| E1 then D | 81 then 60 | |||
| E2 then D | 67 then 98 | |||
| E3 then D | 94 then 81 | |||
| E1 then D | 39 then 70 | |||
| E1 then D | 43 then 63 | |||
| D | 83 | |||
| E1 then D | 32 then 64 | |||
| E2 then D | 83 then 58 | |||
| E3 then D | 84 then 79 | |||
| D | 87 | |||
| E1 then D | 29d | |||
| E2 then D | 43d | |||
| E3 then D | 34d | |||
| D | 70 | |||
| E1 then D | 40d | |||
| E2 then D | 82d | |||
| E3 then D | 74d | |||
| D | 52 | |||
| D | 91 | |||
| E4 then D | 77d | |||
| E2 then D | 83d | |||
| E3 then D | 42d | |||
| D | 94 | |||
| E2 then D | 67d | |||
| E3 then D | 40d | |||
| D | 91 | |||
| E4 then D | 67d | |||
| E2 then D | 67d | |||
| D | 47 | |||
| E2 then D | 59d | |||
| D | 91 | |||
| E4 then D | 64d | |||
| E2 then D | 53d | |||
| E3 then D | 29d | |||
aDetermined by analysis of the product by 500 MHz 1H NMR spectroscopy. bThe suffix refers to the identity of the R substituent: a, R = H; b, R = isoxazole-5-carbonyl; c, R = pyridine-3-carbonylamino; d, R = morpholine-4-carbonyl; cMethods: D: aq HF, MeCN–CH2Cl2; E1: isoxazole-5-carbonyl chloride (2.0 equiv), Et3N (3.0 equiv), DMAP (1.0 equiv), CH2Cl2; E2: pyridine-3-isocyanate (2.0 equiv), Et3N (3.0 equiv), DMAP (1.0 equiv), CH2Cl2; E3: morpholine-4-carbonyl chloride (2.0 equiv), Et3N (3.0 equiv), DMAP (1.0 equiv), CH2Cl2; E4: isoxazole-5-carbonyl chloride (2.0 equiv), pyridine; dYield over two steps.